This announcement is a separate document:
宜明昂科-B：(1) 2023年度董事會工作報告；(2) 2023年度監事會工作報告；(3) 2023年年度報告；(4) 2023年度財務決算報告及2024年度財務預算報告；(5) 2023年度利潤分配方案；(6) 委任執行董事；(7) 續聘核數師；(8) 2024年度董事薪酬方案；(9) 2024年度監事薪酬方案；(10) 發行新股份的一般授權及股東週年大會通告
IMMUNEONCO-B: (1) 2023 WORK REPORT OF THE BOARD OF DIRECTORS;(2) 2023 WORK REPORT OF THE SUPERVISORY COMMITTEE;(3) 2023 ANNUAL REPORT;(4) 2023 FINAL FINANCIAL REPORT AND 2024 FINANCIAL BUDGET REPORT;(5) 2023 PROFIT DISTRIBUTION PLAN;(6) APPOINTMENT OF EXECUTIVE DIR
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.